Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kühne Holding AG is a Swiss-based private holding company with a diverse portfolio, recently expanding into healthcare and pharmaceuticals by acquiring Aenova Group, a major pharma CDMO. It is most notable for holding controlling stakes in logistics (Kühne + Nagel International), shipping (Hapag-Lloyd), airline (Deutsche Lufthansa), and chemical distribution (Brenntag SE) companies, and as of August 2024, owning majority control of Aenova Group, one of the world’s largest CDMOs.[2][4][5][6][8][10]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kühne Holding.